These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31673761)

  • 1. Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.
    Laberge L; Gallais B; Auclair J; Dauvilliers Y; Mathieu J; Gagnon C
    J Neurol; 2020 Feb; 267(2):461-468. PubMed ID: 31673761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue in myotonic dystrophy type 1: a seven-year prospective study.
    Peric S; Bjelica B; Bozovic I; Pesovic J; Paunic T; Banovic M; Brkusanin M; Aleksic K; Basta I; Pavicevic DS; Stojanovic VR
    Acta Myol; 2019 Dec; 38(4):239-244. PubMed ID: 31970322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of Daytime Sleepiness and Fatigue Scales in Myotonic Dystrophy Type 1.
    Laberge L; Gallais B; Auclair J; Dauvilliers Y; Côté I; Mathieu J; Gagnon C
    Can J Neurol Sci; 2022 Mar; 49(2):287-290. PubMed ID: 33875033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep complaints in patients with myotonic dystrophy.
    Laberge L; Bégin P; Montplaisir J; Mathieu J
    J Sleep Res; 2004 Mar; 13(1):95-100. PubMed ID: 14996041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?
    Laberge L; Dauvilliers Y; Bégin P; Richer L; Jean S; Mathieu J
    Neuromuscul Disord; 2009 Jun; 19(6):397-402. PubMed ID: 19403309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients.
    Laberge L; Mathieu J; Auclair J; Gagnon É; Noreau L; Gagnon C
    Eur Neurol; 2013; 70(5-6):308-15. PubMed ID: 24158106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for the reliability and validity of the Fatigue and Daytime Sleepiness Scale.
    Gallais B; Gagnon C; Forgues G; Côté I; Laberge L
    J Neurol Sci; 2017 Apr; 375():23-26. PubMed ID: 28320135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
    Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a 12-week Strength Training Program on Fatigue, Daytime Sleepiness, and Apathy in Men with Myotonic Dystrophy Type 1.
    Gallais B; Roussel MP; Laberge L; Hébert LJ; Duchesne E
    J Neuromuscul Dis; 2022; 9(5):629-639. PubMed ID: 35848033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.
    Hermans MC; Merkies IS; Laberge L; Blom EW; Tennant A; Faber CG
    Muscle Nerve; 2013 Jan; 47(1):89-95. PubMed ID: 23042586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daytime sleepiness and myotonic dystrophy.
    Laberge L; Gagnon C; Dauvilliers Y
    Curr Neurol Neurosci Rep; 2013 Apr; 13(4):340. PubMed ID: 23430686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation.
    Dauvilliers YA; Laberge L
    Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.
    Lam EM; Shepard PW; St Louis EK; Dueffert LG; Slocumb N; McCarter SJ; Silber MH; Boeve BF; Olson EJ; Somers VK; Milone M
    Neurology; 2013 Jul; 81(2):157-64. PubMed ID: 23749798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).
    Heatwole C; Bode R; Johnson N; Quinn C; Martens W; McDermott MP; Rothrock N; Thornton C; Vickrey B; Victorson D; Moxley R
    Neurology; 2012 Jul; 79(4):348-57. PubMed ID: 22786587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1.
    Ho G; Widger J; Cardamone M; Farrar MA
    Sleep Med; 2017 Apr; 32():92-96. PubMed ID: 28366348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
    Puymirat J; Bouchard JP; Mathieu J
    Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.
    Gibbs JW; Ciafaloni E; Radtke RA
    Sleep; 2002 Sep; 25(6):662-5. PubMed ID: 12224846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study.
    Yu H; Laberge L; Jaussent I; Bayard S; Scholtz S; Raoul M; Pages M; Dauvilliers Y
    Sleep; 2011 Feb; 34(2):165-70. PubMed ID: 21286250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1.
    Sansone VA; Proserpio P; Mauro L; Biostat AL; Frezza E; Lanza A; Rogliani P; Pezzuto G; Falcier E; Aggradi CF; Pirola A; Rao F; Roma E; Galluzzi C; Spanetta M; Cattaneo F; Rubino A; Agostoni EC; Amico F; Zanolini A; Izzi F; Greco G; Romigi A; Liguori C; Nobili L; Placidi F; Massa R
    J Clin Sleep Med; 2021 Dec; 17(12):2383-2391. PubMed ID: 34170223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.